Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CO2 Laser Therapy System (K106)

K-Number: K252519 · 2025-11-07

Decision Date2025-11-07
Product CodeGEX
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

CO2 Laser Therapy System (K106) is a medical device manufactured by Hebei Keylaser Sci-Tech Co.,Ltd. It received FDA 510(k) clearance on 2025-11-07 under approval number K252519. The device is classified under product code GEX. It was reviewed by the SU advisory panel. Product code GEX falls under the category of Gastroenterology, which includes gastrointestinal diagnostic and therapeutic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CO2 Laser Therapy System (K106)?

CO2 Laser Therapy System (K106) is a medical device that received FDA 510(k) clearance on 2025-11-07. It is manufactured by Hebei Keylaser Sci-Tech Co.,Ltd. The 510(k) number is K252519.

When was CO2 Laser Therapy System (K106) approved by the FDA?

CO2 Laser Therapy System (K106) received FDA 510(k) clearance on 2025-11-07, under approval number K252519.

What company makes CO2 Laser Therapy System (K106)?

CO2 Laser Therapy System (K106) is manufactured by Hebei Keylaser Sci-Tech Co.,Ltd.

What is the FDA product code for CO2 Laser Therapy System (K106)?

The FDA product code for CO2 Laser Therapy System (K106) is GEX. This falls under the Gastroenterology category.

Related Clinical Trials

Related PubMed Literature

Other Devices by Hebei Keylaser Sci-Tech Co.,Ltd

Related Devices (Code: GEX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.